• Decreases respiratory problems and stops economic losses.
  • Formula 2+1 against respiratory disease: 2 antibiotics and 1 mucolytic.
  • Bronchomucolytic.
COMPOSITION PER ML
Lincomycin hydrochloride 50 mg Spectinomycin sulfate 100 mg Bromhexine hydrochloride 2.5 mg
DOSAGE AND ADMINISTRATION METHODS
1 ml of medication/4 kg of l.w./day for 3-5 consecutive days by intramuscular route.
Respect a maximum volume per point of injection of 20 ml.
Anticipate a sufficient separation between the points of injection when several points of administration are necessary.
product form
  • Solution for injection
Trust innovation

Continued growth and improvement

At draxpharma, we understand that consistent growth is only achieved with a firm commitment to evolution and improvement. Ideas and suggestions for new partnerships, new products and new technologies are always welcome.

Change country

The Huvepharma® distribution network covers 90 countries in 6 continents. Please select a country from the list below to see the products and services available in that region.

To view all products and services, select Global from the dropdown menu or click .

Africa

Asia

Europe

North America

Oceania

South America

Change language

Huvepharma has a remarkable distribution network which covers 90 countries in 6 continents. To offer you the best services, we ask you to select your country.

Europe

Your browser is out of date!

Update your browser to view this website correctly. Update my browser now